Back to basics: early diagnosis and compliance improve final height outcome in congenital adrenal hyperplasia.
Schwartz
R P
RP
D000293:Adolescent; D000312:Adrenal Hyperplasia, Congenital / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy*; D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001827:Body Height; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D015997:Neonatal Screening; D010349:Patient Compliance / Q000523:psychology; D013997:Time Factors; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D006854:Hydrocortisone